Skip to content

Role of Laghumanjisthadi Ghana and Raktamokshan in Gout.

Randomized controlled clinical trial to evaluate the efficacy of Laghumanjisthadi Ghana and Raktamokshan in Vatarakta with special refence to Gout.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071793
Enrollment
60
Registered
2024-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

None listed

Sponsors

Dr Pranoti Tukaram Khandekar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having clinical signs and symptoms of vatrakta with special reference to gout like Sandhi toda(jiont pricking pain),Sandhi daha(burning sensation),Sparshasahatva(Tenderness),Sandhi shotha (swelling),Raga (redness or discolouration of joint)described in aaaaaaaaayurvedic classics without any bar of caste ,sex,religion . 2 Patient having serum uric acid level above 6

Exclusion criteria

Exclusion criteria: 1 Patients having chronicity of vatrakta more than 5 years 2 Patients on Anti platelet aggregation drugs 3 Patients on anti coagulant drugs 4 Patients having bleeding disorders 5 Patients contraindicated for for Raktamokshana 6 Pregnant and Lactating mothers 7 Patients with illness like HIV, Malignancy,Cardiac disease ,Major Liver Disorders ,Uncontrolled Hypertension , End stage Renal disease

Design outcomes

Primary

MeasureTime frame
To Evaluate the efficacy Hypourecemic effect of Laghumanjisthadi Ghana and Raktamokshan in the management of Vatarakta.Timepoint: 21 days

Secondary

MeasureTime frame
1 To evaluate the Hypourecemic effect of Laghumanjisthadi Ghana & Raktamokshan in Vatarakta. 2.To study adverse effect of Laghumanjisthadi Ghana if any 3 To study adverse effect of Raktamokshan if any 4.To study etiopathology of Vatarakta.Timepoint: 21 days

Countries

India

Contacts

Public ContactDr Pranoti tukaram Khandekar

Seth Chandanmal Mutha Aryangla Vaidyak Mahavidyalaya, Satara

sameershubha85@gmail.com7507043414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026